Why Sensex, Nifty rallied today; what's next for the stock market?

 

Indian equity benchmarks gained sharply on Friday amid hopes of easing geopolitical tensions in West Asia, lower crude oil prices and strength in the rupee.

The 30-share BSE Sensex pack surged 1,695.40 points or 2.30 per cent to settle at 75,527.95, while the NSE Nifty50 index jumped 461.30 points or 1.99 per cent to close at 23,622.90. The broader market outperformed the benchmark indices, with Nifty Midcap100 rising 2.43 per cent and Nifty Smallcap100 advancing 2.80 per cent.

Ankur Punj, MD & Business Head at Equirus Wealth, said, "A likely peace solution to the ongoing war between the US and Iran over the next few days fuelled a massive rally and pushed oil prices below the $90 per barrel mark."

He added, "Strong global market recovery triggered broad-based buying support, while a sharp recovery in the rupee against the dollar also aided sentiment. While the FII fund exodus from domestic equities remains a concern, the emerging peace deal significantly reduces the risk of renewed tension, offering overseas investors greater confidence to hold or even rebuild their positions in local shares."

Kranthi Bathini, Director of Equity Strategy at WealthMills Securities, said the recent sharp fall in crude oil prices has boosted market sentiment, with bulls taking charge.

Hariprasad K, Sebi-registered Research Analyst and Founder, Livelong Wealth, stated, "Indian equities witnessed a strong turnaround session today, marking one of the strongest bullish moves in recent sessions. The rally was driven by a sharp improvement in global risk sentiment, easing geopolitical concerns and renewed confidence across risk assets."

He also said, "The biggest trigger for today's move was the sudden shift in tensions in West Asia. Expectations of a potential diplomatic resolution between the US and Iran, along with the cancellation of planned military action, reduced fears of a wider conflict. This triggered a global risk-on rally, with investors moving back into equities after recent defensive positioning."

"As concerns around supply disruptions and Strait of Hormuz risks eased, oil prices corrected significantly. Lower crude prices directly benefit India by reducing import costs, easing inflationary pressure and improving the broader macroeconomic outlook," Hariprasad added.

He also stated that the rupee strengthened, trading near the 94.90 zone against the US dollar, supported by lower crude prices and improved global sentiment. Hariprasad noted that currency stability provides additional comfort for foreign investors and helps reduce pressure on India's external balances.

What's next for the stock market?

While Friday's rally reflected improving sentiment, Vinod Nair, Head of Research at Geojit Investments, said, "The year has been challenging for India, with the economy first steering the impact of US tariffs and subsequently contending under the energy-driven shock. While conditions on both fronts have improved, the economy still faces a demanding phase marked by inflationary pressures, weak monsoon, and a moderation in both global and domestic growth momentum."

He added, "A key near-term variable is the new policy direction of the US Fed under the new chair, with a revised framework. The upcoming Fed meeting is drawing heightened attention as markets assess the balance between growth and persistent inflation pressures. While the economic stance has emerged under elevated bond yields, resilient labour markets, and sticky inflation may limit the scope for aggressive easing, making the situation challenging."

Ajit Mishra – SVP, Research, Religare Broking, stated, "Market participants remain watchful of foreign institutional flows and further developments on the geopolitical front. Technically, Nifty has staged a decisive rebound after defending the crucial 23,000 support zone and reclaiming the key resistance area around 23,500, which coincides with the 20-day EMA. Sustaining above this zone could pave the way for a move towards the 23,800–24,200 band in the near term. On the downside, the 23,100–23,300 region is now expected to act as immediate support in the event of any profit-taking."

The Indian stock market witnessed a massive, broad-based relief rally today (June 12, 2026). The BSE Sensex skyrocketed by 1,695.40 points (2.30%) to settle at 75,527.95, while the NSE Nifty 50 surged 461.30 points (1.99%) to reclaim and close above the crucial psychological level at 23,622.90.

This surge added over ₹10 lakh crore to the wealth of investors in a single session.

Why Did the Stock Market Rally Today?

The explosive rebound was primarily driven by a dramatic easing of global geopolitical risks and its positive cascading effect on macroeconomics:

• US-Iran Peace Breakthrough: The biggest sentiment catalyst came from Washington. US President Donald Trump announced that a diplomatic breakthrough was close at hand and a peace agreement to end the conflict with Iran could be finalized as early as this weekend. He also backed away from previous threats of further military action. This raised strong hopes for the formal reopening of the critical Strait of Hormuz to global maritime shipping.

• Crude Oil Plunged Below $90: Because the risk premium evaporated, global crude prices tanked. Brent crude fell roughly 4%, sliding well below the crucial mark to trade near $87–$89 per barrel (down from highs of over $120 earlier in the year). As the world's third-largest oil importer, India heavily benefits from cheaper oil via reduced import bills, a narrowing trade deficit, and cooled domestic inflation.

• Rupee and Volatility Relief: Backed by sliding oil and a weakening US Dollar, the Indian Rupee appreciated sharply by about 60–65 paise to reach 95.25 against the greenback. Concurrently, the market's fear gauge, India VIX, dropped around 4% down to the 15 level, indicating significantly reduced investor anxiety.

• Global Equity Tailwinds: Dalal Street tracked a massive global wave of risk-on appetite. Overnight US markets closed higher, and Asian peers logged blockbuster gains—with South Korea's Kospi leading the pack up over 8% and Japan's Nikkei up around 3%.

• Sectoral Tailwinds & RBI Support: Buying was broad-based across all 30 Sensex components. Rate-sensitive banking and financial stocks were heavily lifted by recent RBI liquidity-enhancing measures (like the concessional forex swap facility). Oil-dependent or West-Asia-exposed sectors—such as Aviation (IndiGo), Infrastructure (L&T), Paints, Tyres, and OMCs—led the charge.

What’s Next for the Stock Market?

While today's price action signals a strong structural rebound, market experts suggest tracking a few vital metrics to see if this momentum sustains over the coming weeks:

1. Technical Levels to Watch (Nifty 50)

The technical structure has materially improved with Nifty reclaiming the 23,500 zone.

• Upside Targets: Analysts point out that staying decisively above 23,500 opens up a clear runway toward 23,700, with potential to test higher resistance zones if momentum carries.

• Downside Support: The immediate short-term support moves up to 23,300–23,350. A worst-case trend reversal below 23,100 would be required to bring the bears back into play.

2. Follow-through on the Peace Treaty

The sustainability of this rally hinges entirely on whether the US-Iran peace agreement is formally signed over the weekend. Any unexpected hitch in diplomacy or logistical delays in fully reopening shipping lines could bring back brief bouts of volatility.

3. FII Short-Covering vs. Sector Rotation

Because Foreign Institutional Investors (FIIs) have held heavy short positions recently, this sharp drop in oil is highly likely to trigger aggressive short-covering, which could add structural fuel to the market's upward trajectory. However, domestic investors should keep an eye on whether FIIs actively allocate fresh capital back into India or lean toward tech-heavy Asian markets (like Taiwan and South Korea) where the AI-driven tech rally is regaining rapid traction.

4. Sector Focus

Expect continued margin expansion and positive bias in input-cost-sensitive sectors like paints, adhesives, lubricants, special chemicals, and aviation if Brent crude establishes a structural base below $90. Capital goods and infrastructure plays with structural exposure to West Asia are also poised for a strong operational revival.

Share:

Read More

Bonus issue alert! This smallcap company announced a 2:5 bonus issue. Do you own?

 

Hardwyn India, a provider of kitchen, door, glass, wardrobe and sliding hardware solutions, has announced a bonus issue in the ratio of 2:5 for its shareholders.

In an exchange filing released on Friday, Hardwyn India said that its board of directors met on June 5 to consider and approve the issuance of “bonus equity shares in the ratio of 2:5 i.e., 2 bonus equity shares of Rs 1 each fully paid-up for every 5 equity shares of Rs 1 each fully paid-up held by the shareholders of the company as on the record date, by capitalization of free reserves/retained earnings, subject to the approval of members in Extraordinary General Meeting”.

Along with the bonus issue, Hardwyn’s board also approved increasing the company’s authorised share capital from the existing Rs 50 crore, divided into 50 crore shares with a face value of Rs 1 each, to Rs 70 crore, divided into 70 crore equity shares with a face value of Rs 1 each.

The Extraordinary General Meeting (EGM) where the bonus issue will be voted on is scheduled for July 3 this year. The company set June 26 as the cut-off date to determine who can vote in the EGM.

Hardwyn India bonus issue record date

As part of the bonus issue, the company proposed to issue nearly 19.54 crore new shares for its shareholders, using its free reserves or retained earnings, which stood at Rs 19.65 crore at the end of the financial year 2026.

The record date to determine the eligibility of shareholders for the 2:5 bonus issue is yet to be announced. Hardwyn said that the bonus issue is expected to be dispatched within two months of the board’s approval, that is, by August 4.

A bonus issue consists of free shares distributed by a company from its reserves and is often seen as a sign of strong financial health and growth prospects. While the issue of bonus shares increases the total number of outstanding shares, it does not change the company’s market capitalisation. However, it can improve liquidity and affordability, allowing more investors to add shares of the company to their portfolio.

Anand Rathi names Hardwyn India as its pick of the month

Anand Rathi Investment Services named Hardwyn India as its pick of the month in its report dated June 2, highlighting that the stock is currently trading near its 20 DEMA support. “Additionally, the DMI indicators are positively aligned, while the ADX is placed at 32, reflecting strong trend strength and supporting the possibility of further upside momentum,” it said.

“Therefore, traders may consider accumulating the stock in the Rs 24.50–25.50 zone, with a stop-loss at Rs 22.50. On the upside, the stock has the potential to move towards the Rs 30 target in the near term, provided it sustains above the mentioned support levels,” it added. The target price implies an upside potential of nearly 23% from the stock’s previous closing price of Rs 24.41 apiece.

Hardwyn India share price

Hardwyn India shares declined nearly 1% to trade at Rs 24.21 apiece, at around 11.05 am on Monday. The stock has fallen around 4% in five days and 2% in one month. Overall, the shares of the company are, however, up over 44% in 2026 so far.

(Disclaimer: Recommendations, suggestions, views and opinions given by the experts are their own. These do not represent the views of The Economic Times)

While I don't own any stocks or manage a personal investment portfolio (being an AI!), a 2:5 bonus issue announcement is always an interesting event for shareholders to track.

To help you evaluate what this means for the company and its investors, here is a breakdown of how a 2:5 bonus issue works and what you should look out for:

What does a 2:5 Bonus Issue mean?

In a 2:5 bonus ratio, the company is offering 2 free bonus shares for every 5 existing shares you hold in your portfolio.

• Example: If an investor owns 100 shares of this smallcap company, they will receive 40 additional shares entirely for free $(100 \times \frac{2}{5})$, bringing their total holdings to 140 shares.

  
  
  

Does it change the investment value immediately?

No. A bonus issue is essentially a book adjustment where the company moves funds from its free reserves to its share capital account. Because the total number of outstanding shares increases, the stock price adjusts downward proportionately on the Ex-Bonus Date.

If the stock was trading at ₹140 before going ex-bonus, the price would theoretically adjust to ₹100 post-bonus, meaning the total value of your investment remains exactly the same at the exact moment of the split.

Why do smallcap companies announce bonus issues?

1. Boosts Liquidity: Smallcap stocks can sometimes have lower trading volumes. Lowering the price per share makes the stock more affordable and attractive to retail investors, increasing liquidity.

2. Positive Market Signal: It signals management's confidence in the company’s future earnings and financial health, as only fundamentally stable companies can capitalize reserves to issue bonus shares.

3. Future Dividend Advantages: If the company maintains its dividend per share amount in the future, investors will receive higher total payouts because they now own more shares.

Key Dates to watch if you are tracking this stock:

• Record Date: The cutoff date set by the company. You must officially be in the company's share registry on this day to be eligible for the free shares.

  
  
  

• Ex-Bonus Date: Typically one working day before the record date. To get the bonus, you must buy the stock before this date. If you buy it on or after the ex-bonus date, the previous owner gets the bonus, and you buy it at the adjusted lower price.

If you are tracking a specific smallcap company that just made this announcement, feel free to share the name! We can look into its current financials, record dates, or market sentiment.

Share:

Read More

How long will we live after turning 70? A straightforward test might provide the answer

 

As individuals grow older and reach a certain stage in life, the likelihood of developing health conditions that may lead to death increases. Given the numerous influencing factors, predicting short-term mortality risk has seemed complex, yet a recent study suggests this could now be determined with a simple blood test.

Research conducted by Duke Health, in collaboration with the University of Minnesota and published in the journal Aging Cell, found that certain small RNA molecules known as piRNAs in blood can provide highly accurate information about the survival prospects of older adults over a minimum of two years.

RNA (ribonucleic acid) is a vital single-stranded molecule responsible for copying, transporting, and translating genetic information from DNA to produce proteins. When RNA interacts with the Piwi protein, it forms piRNA, which plays an essential role in development, regeneration, and immune function, as highlighted in the study referenced by Newsweek.

Based on the findings of this research, scientists emphasize that the presence of these small molecules in blood enables the short-term survival risk for people aged 71 and older to be assessed.

This represents a significant breakthrough, as it will be highly valuable in medicine for identifying which individuals are at greater risk of severe health deterioration and reduced healthy lifespan—an assessment that becomes increasingly difficult as people age.

Lead researcher Virginia Byers Kraus, professor at Duke University School of Medicine, noted that beyond the discovery itself, the most remarkable aspect is that the method used is a simple blood test—a minimally invasive approach that can be crucial for identifying risk and implementing strategies to encourage healthy aging among patients.

The study involved blood samples from 1,200 adults aged 71 and above, revealing that those with lower concentrations of certain piRNA types had exponentially higher chances of surviving beyond two years.

To enhance the reliability of the findings, as reported by Newsweek, blood samples from a cohort study stored in North Carolina biobanks (USA) were utilized. These samples had already been used in previous Duke Health research and included documented survival data.

"The combination of just a few piRNA was the most robust predictor of two-year survival in older adults, outperforming age, lifestyle habits, or any other health indicator we considered," stated Byers Kraus, as quoted by Euronews.

To make these comparisons, researchers employed artificial intelligence and machine learning techniques, which enabled them to analyze 187 clinical factors potentially influencing short-term survival and 828 RNAs present in the 1,200 blood samples.

Among all the piRNAs examined, only six were found to predict short-term survival capacity in the individuals whose blood was analyzed, achieving an accuracy rate of 86%. This conclusion was validated through a second analysis with similar parameters.

When scientists and medical researchers look at how long a person will live after turning 70, they look less at specific disease diagnoses and more at a person's biological age—how well their body and brain are actually functioning.

Recent studies have highlighted a few remarkably straightforward, low-tech tests that can be performed in under a minute. These tests serve as powerful indicators of longevity for those over 70.

1. The 10-Second Balance Test (Single-Leg Stance)

One of the most notable "straightforward tests" gaining attention in clinical medicine is the simple one-legged balance test.

• The Test: Remove your shoes and socks, place one foot against the back of your opposite lower leg, keep your arms at your sides, and try to stand on one leg for 10 seconds.

• What it Predicts: A major study published on the link between balance and longevity found that middle-aged and older adults who were unable to successfully hold this pose for 10 seconds had an 84% higher risk of death from any cause within the next decade compared to those who could.

• Why it Works: Balance isn't just about your feet; it requires a complex synchronization between brain health, vision, muscular strength, and blood circulation. A decline in balance often indicates underlying frailty, a higher risk of dangerous falls, or early cardiovascular and neurological changes.

2. The Sitting-Rising Test (SRT)

Developed by physicians to evaluate musculoskeletal fitness, this quick test measures how well your body moves against gravity.

• The Test: Standing barefoot in a clear space, cross your legs and slowly lower yourself all the way down to a sitting position on the floor. Then, try to stand back up.

• The Scoring: You start with a perfect score of 10. Every time you use a hand, arm, knee, or the side of your leg for support to push yourself up or steady yourself down, you subtract 1 point.

• What it Predicts: Research shows that older adults who score 8 or higher have a significantly longer life expectancy. Conversely, those with low scores (needing multiple hands or knees to get up) have a vastly higher mortality risk over the following six years. It serves as a direct reflection of lower-body power, core strength, and flexibility.

3. The "Grocery Shopping" Physical Function Test

A Duke University study specifically tracked individuals over the age of 71 to find the absolute closest "proximal causes" of living another 2, 5, or 10 years.

• They discovered that the leading predictor of 2-year and 5-year survival wasn't a lab value—it was basic everyday physical function, defined simply as a person's independent ability to go grocery shopping or perform light housecleaning chores without assistance.

4. The 90-Second Verbal Fluency Test

Longevity isn't just physical; it is also cognitive. A study using data from the Berlin Aging Study tracked individuals aged 70 to 103 and found a simple cognitive test that predicted life expectancy better than traditional memory tests.

• The Test: A person is given 90 seconds to name as many animals as possible, or as many words starting with a specific letter (like "S").

• What it Predicts: Those who scored in the top 25% lived nearly nine years longer than those in the bottom 25%. A rapid ability to retrieve words demonstrates highly connected, healthy brain networks, which correlates strongly with systemic vitality and resilience against cognitive decline.

  
  
  

The Good News: These Aren't a Fixed Fate

The most encouraging takeaway from all of this research is that these tests measure modifiable traits. If a 70-year-old struggles to stand on one leg or get up from the floor, it is not a permanent sentence. Simple interventions like regular walking, light resistance training (such as squats from a chair), tai chi for balance, and staying socially and mentally engaged can rapidly improve these scores—and, by extension, add vibrant, healthy years to one's life.

Share:

Read More

‘My blood sugar runs 110 to 140 mg/dL throughout the day. Is that normal?’

 

Is your blood sugar consistently high? (Photo: Freepik)

What happens to the body when your blood sugar numbers are consistently high? That's exactly what a Quora user wanted to know: 'My blood sugar runs 110 to 140 mg/dL throughout the day. Is that normal?' To understand better, we reached out to medical experts.

Dr Aarti Ullal, physician and diabetologist, Gleneagles Hospital, Parel, Mumbai, said that whether a glucose reading between 110 and 140 mg/dL throughout the day is high or not depends on timing, health history, symptoms, and when and how you check the numbers.

"If those numbers are after meals, they’re fairly acceptable for most adults. But if your readings stay in that range even on an empty stomach or before breakfast, it may signal the early stages of impaired fasting glucose, or what we commonly call prediabetes. It’s not a diagnosis of diabetes, but it’s your body’s way of warning you that things could move in that direction if you don’t make changes," said Dr Pranav Ghody, consultant endocrinologist and diabetologist, Wockhardt Hospitals, Mumbai Central.

For people without diabetes, a normal fasting blood glucose is about 70–99 mg/dL; a two-hour post-meal (postprandial) value is usually below 140 mg/dL. "For people with diabetes, typical targets are broader (pre-meal 80–130 mg/dL, 1–2-hour post-meal under 180 mg/dL), so 110–140 might be acceptable depending on individualised goals," added Dr Ullal.

What causes such elevated numbers?

Several factors, like stress, poor sleep, missed meals, high-carb snacks, or even dehydration, can cause temporary spikes. Dr Ghody said that sometimes, people who are otherwise healthy see higher numbers because they’re checking right after tea, coffee, or a short nap. "However, if this range appears consistently, the next step is to consult with a qualified physician or an endocrinologist," said Dr Ghody.

Is it possible to reverse or control this without medicines?

In most cases, early intervention through diet and exercise can normalise sugar levels within weeks or months. "Think of it as pressing pause on diabetes. The key is consistency; you can’t outsmart sugar levels with quick fixes, but you can outlast them with steady habits," said Dr Ghody.

diet

Here's what you should consider (Photo: Freepik)

Related video: 10 fruits that can raise blood sugar levels & 10 that are safe to eat (The Spicy Chefs)

The Spicy Chefs

10 fruits that can raise blood sugar levels & 10 that are safe to eat

There's something about fruit that makes it feel like a

Current Time 0:00

/

Duration 6:37

0

View on Watch

Actionable steps

*Check a true fasting level (after 8 hours without calories) and a 1–2 hour postprandial reading.

*Consider getting an HbA1c test to estimate average glucose over three months.

*Discuss results with your primary care clinician who may recommend lifestyle changes (weight management, healthy diet, regular physical activity) and possibly further testing such as an oral glucose tolerance test or starting medication.

"If you have symptoms (excessive thirst, frequent urination, unexplained weight loss, blurry vision) or very high readings above 180–200 mg/dL, seek medical attention promptly," said Dr Ullal.

Also Read | Why is fasting glucose high (around 105 mg/dL) in a non-diabetic?

Routine monitoring and timely discussion with your clinician will clarify whether lifestyle changes are sufficient or whether medication is advisable to lower future cardiovascular and microvascular risk.

Also, make your plate more colourful. "Half should be vegetables, one-quarter lean protein, and one-quarter whole grains. Walk for 30 minutes a day, preferably after meals, to help your body use up glucose efficiently. Keep an eye on your waistline even a 5–7 per cent weight loss can bring blood sugar back to normal. Manage stress, sleep at least 7 hours, and stay hydrated," said Dr Ghody.

DISCLAIMER: This article is based on information from the public domain and/or the experts we spoke to. Always consult your health practitioner before starting any routine.

Whether these blood sugar readings are considered normal depends entirely on when you are testing and whether you have a pre-existing diagnosis of diabetes or prediabetes.

Here is how your numbers (110 to 140 mg/dL) stack up across different scenarios:

Scenario 1: If you do NOT have diabetes

• Fasting or Before Meals: A normal fasting blood sugar level for someone without diabetes is under 100 mg/dL. If your numbers are consistently between 110 and 140 mg/dL before you've eaten anything in the morning, this is elevated and falls into the prediabetes range.

• After Meals (Postprandial): A normal blood sugar level two hours after a meal is under 140 mg/dL. If your readings are sitting at 110 to 140 mg/dL after eating, they are considered normal and healthy.

Scenario 2: If you HAVE been diagnosed with diabetes

• An Excellent Range: For most adults managing diabetes, the American Diabetes Association (ADA) recommends a target fasting range of 80 to 130 mg/dL and a post-meal range of under 180 mg/dL.

• If your blood sugar stays between 110 and 140 mg/dL all day long, you are managing your levels exceptionally well and keeping them within a very safe, stable window.

Key Questions to Consider

To get a clearer picture of what these numbers mean for you, it is helpful to look at the context:

1. When exactly are you testing? Are these numbers appearing first thing in the morning, right before lunch, or a couple of hours after dinner?

2. What instrument are you using? Are you using a standard finger-stick glucose meter, or do you wear a Continuous Glucose Monitor (CGM)? If you are using a CGM, a steady line between 110 and 140 mg/dL represents excellent glycemic variability and a high "Time in Range."

3. What is your history? Have you ever been told by a doctor that you have insulin resistance, prediabetes, or type 2 diabetes?

Next Steps & Recommendations

Because single daily snapshots on a home meter don't tell the whole story, the best way to evaluate these numbers is to schedule an appointment with your primary care physician.

Ask them to order a Routine HbA1c blood test. Unlike daily checks, the HbA1c test measures the percentage of hemoglobin coated with sugar, providing a precise 3-month average of your blood sugar levels. This test is the gold standard for definitively confirming whether your metabolism is functioning normally or if you require any dietary or lifestyle adjustments.

In the meantime, keep a brief log of your readings alongside the times you ate to share with your doctor. If you'd like to share when you typically see these numbers or if you're tracking a specific health goal, that could help narrow down what's happening!

Share:

Read More